Clinical Trials

24 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00054015 2013-11-06

3-AP in Treating Patients With Advanced Prostate Cancer

Genitourinary

Prostatic Neoplasms

NCT00064064 2013-11-06

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00077545 2013-10-08

3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction

39 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00085371 2013-10-08

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

116 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00293345 2013-09-30

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

DermatologicLymphoidOther hematologic neoplasm

30 enrolled

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00064051 2013-08-02

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Gastrointestinal

Pancreatic Neoplasms

NCT00004213 2013-07-18

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006218 2013-07-18

3-AP in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

NCT00024323 2013-07-18

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

NCT00064090 2013-07-18

3-AP and Cytarabine in Treating Patients With Hematologic Cancer

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00079014 2013-05-16

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

36 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00084877 2013-05-16

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

36 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00077415 2013-05-15

3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer

31 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00077350 2013-02-27

A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer

48 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00077181 2013-01-24

3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies

LymphoidOther hematologic neoplasm

48 enrolled

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00081276 2013-01-24

3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

48 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT00335998 2013-01-11

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies